کتابخانه دیجیتال دانشگاه علوم پزشکی بیرجند
    • [نمايش بزرگتر]
    • [نمايش کوچکتر]
  • صفحه 
     از  0
  • [صفحه قبل]
  • [صفحه بعد]
  • [نمایش تمام صفحه]
  • [بستن]
 
Vascular medicine : a companion to Braunwald’s heart disease

اطلاعات کتابشناختی

Vascular medicine : a companion to Braunwald’s heart disease
Author :  
Publisher :   Elsevier,
Pub. Year  :   2020
Subjects :   Vascular Diseases -- diagnosis. Vascular Diseases -- therapy.
Call Number :   ‭WG 505 V331 2020

جستجو در محتوا

ترتيب

فهرست مطالب

  • Instructions for online access (3454)
  • Title page (2)
  • Table of Contents (5)
  • Copyright (37)
  • Dedication (40)
  • Contributors (42)
  • Foreword (54)
  • Preface (57)
    • Acknowledgments (61)
  • Series page (62)
  • Part I: Biology of Blood Vessels (66)
    • 1: Vascular Embryology and Angiogenesis (67)
      • Abstract (69)
      • Tunica intima: endothelium (72)
      • Tunica media: smooth muscle and extracellular matrix (86)
      • Tunica adventitia (100)
      • Summary (103)
    • 2: The Endothelium (121)
      • Abstract (123)
      • Homeostatic functions of the endothelium (125)
      • Endothelial heterogeneity (141)
      • Endothelial dysfunction and vascular disease (144)
      • Functional assessment of the endothelium (148)
      • Conclusions (152)
    • 3: Vascular Smooth Muscle (172)
      • Abstract (174)
      • Origins of vascular smooth muscle cells during embryonic development (177)
      • Vascular smooth muscle cell phenotypic modulation (180)
      • Influence of cell-cell and cell-matrix interactions (208)
      • Phenotype-specific vascular smooth muscle cell functions (217)
      • Inflammation and inflammation-related processes (232)
      • Senescence and aging (239)
      • Conclusions (244)
    • 4: Normal Mechanisms of Vascular Hemostasis (277)
      • Abstract (279)
      • Endothelial function and platelet activation (280)
      • The coagulation cascade leading to fibrin formation (283)
      • Fibrinolysis (288)
      • Summary (292)
    • 5: Vascular Pharmacology (298)
      • Abstract (300)
      • The pharmacological framework of drug action (302)
      • Therapeutic intervention and the endothelium (307)
      • Therapeutic intervention and the autonomic vascular innervation (334)
      • Therapeutic intervention and the vascular media (348)
  • Part II: Pathobiology of Blood Vessels (375)
    • 6: Pathobiology of Atherosclerosis (376)
      • Abstract (378)
      • Risk factors for atherosclerosis: traditional, emerging, and on the rise (380)
      • The diversity of atherosclerosis (395)
      • Atherosclerosis: a systemic disease (414)
    • 7: Pathobiology of Aortic Aneurysms (430)
      • Abstract (432)
      • Degradation of the medial extracellular matrix (438)
      • Smooth muscle dysregulation (440)
      • Inflammation and oxidative stress (441)
      • Biomechanical stress (443)
      • Risk factors and genetics of aortic aneurysms (445)
      • Epigenetics/micrornas in aortic aneurysms (448)
      • Conclusion (450)
    • 8: Pathobiology of Thrombosis (457)
      • Abstract (459)
      • Overview of thrombosis (460)
      • Platelets, thrombosis, and vascular disease (463)
      • Inflammation and thrombosis (472)
    • 9: Pathobiology and Assessment of Cardiovascular Fibrosis (481)
      • ABSTRACT (483)
      • Overview of collagen (486)
      • Collagen structure, properties, and relevance to human biology (489)
      • Regulation of collagen synthesis (490)
      • Regulation of collagen metabolism (494)
      • Fibrosis in clinical cardiovascular disease (495)
      • Myocardial fibrosis in specific cardiovascular conditions (499)
      • Biomarkers of myocardial fibrosis (502)
      • Targeting myocardial fibrosis (503)
      • Vascular fibrosis in systemic hypertension (504)
      • Vascular fibrosis in pulmonary arterial hypertension (506)
      • Conclusions (508)
    • 10: Pathobiology of Vasculitis (516)
      • Abstract (518)
      • Large-vessel vasculitis (520)
      • Small-vessel vasculitis (526)
      • Medium-vessel vasculitis (531)
      • Summary (533)
  • Part III: Principles of Vascular Examination (537)
    • 11: The History and Physical Examination (538)
      • Abstract (540)
      • Vascular history (541)
      • Vascular examination (550)
    • 12: Vascular Laboratory Testing (573)
      • Abstract (575)
      • Limb pressure measurement and pulse volume recordings (576)
      • Transcutaneous oximetry (583)
      • Physical principles of ultrasonography (584)
      • Carotid duplex ultrasound (592)
      • Abdominal aorta evaluation (605)
      • Renal artery duplex ultrasonography (610)
      • Peripheral arterial ultrasonography (613)
      • Pseudoaneurysm (621)
      • Arteriovenous fistulae (624)
      • Venous duplex ultrasound (626)
      • Plethysmographic evaluation of venous reflux (635)
      • Vascular laboratory accreditation (636)
    • 13: Magnetic Resonance Imaging (642)
      • Abstract (644)
      • Acknowledgment (645)
      • Basic principles (647)
      • Magnetic resonance angiography techniques (649)
    • 14: Computed Tomographic Angiography (691)
      • Abstract (693)
      • Fundamentals of computed tomography imaging (695)
      • Radiation exposure and radiation dose reduction (701)
      • Emerging technologies in computed tomography (705)
      • Artifacts and pitfalls of computed tomographic angiography (707)
      • Clinical applications of computed tomographic angiography in vascular disease (708)
    • 15: Catheter-Based Peripheral Angiography (748)
      • Abstract (750)
      • Imaging equipment (751)
      • Radiographic contrast (753)
      • Imaging technique (754)
      • Obtaining vascular access (755)
      • Complications of peripheral vascular angiography (787)
  • Part IV: Peripheral Artery Disease (792)
    • 16: The Epidemiology of Peripheral Artery Disease (793)
      • Abstract (795)
      • Symptoms and measures of peripheral artery disease in epidemiology (797)
      • Incidence and prevalence of peripheral artery disease (803)
      • Peripheral artery disease risk factors (810)
      • Interaction and risk factor comparisons (824)
      • Progression of peripheral artery disease (825)
      • Co-prevalence of peripheral artery disease and other atherosclerotic disease (828)
      • Peripheral artery disease as a predictor of mortality and morbidity (830)
    • 17: Pathophysiology of Peripheral Artery Disease (850)
      • Abstract (852)
      • Clinical expressions of peripheral artery disease (854)
      • Hemodynamics in peripheral artery disease (857)
      • Contributors to limb symptoms in peripheral artery disease: beyond arterial stenosis (861)
      • Altered skeletal muscle structure and function in peripheral artery disease (866)
      • Summary (869)
    • 18: Peripheral Artery Disease: Clinical Evaluation (880)
      • Abstract (882)
      • Patient history (883)
      • Critical limb ischemia (888)
      • Physical examination (892)
      • Diagnostic testing (896)
      • Summary (909)
    • 19: Medical Treatment of Peripheral Artery Disease (916)
      • Abstract (918)
      • Interventions to reduce cardiovascular risk and adverse limb events (923)
      • Interventions to improve symptoms and function (948)
      • Summary and conclusion (958)
    • 20: Endovascular Treatment of Peripheral Artery Disease (979)
      • Abstract (981)
      • Patient and lesion selection criteria (983)
      • Technical and procedural considerations (987)
      • Clinical outcomes (992)
      • Conclusions (1004)
    • 21: Reconstructive Surgery for Peripheral Artery Disease (1014)
      • Abstract (1016)
      • Aortoiliac occlusive disease (1018)
      • Infrainguinal Arterial Occlusive Disease (1040)
  • Part V: Renal Artery Disease (1075)
    • 22: Pathophysiology of Renal Artery Disease (1076)
      • Abstract (1078)
      • Epidemiology of renal artery disease (1081)
      • Pathophysiologic consequences of renovascular disease (1082)
      • Renal artery disease and mortality (1107)
    • 23: Clinical Evaluation of Renal Artery Disease (1113)
      • Abstract (1115)
      • Consequences of renal artery stenosis (1119)
      • Physical examination (1123)
      • Diagnosis of renovascular disease (1124)
    • 24: Treatment of Renal Artery Disease (1149)
      • Abstract (1151)
      • Critical functions of the kidney (1152)
      • Medical therapy for renal artery disease (1153)
      • Fibromuscular dysplasia (1154)
      • Atherosclerotic renal artery stenosis (1157)
      • Treatment of unusual causes of renal artery stenosis (1164)
      • Treatment of renal artery aneurysms (1165)
      • Surgical management of atherosclerotic renal artery disease (1166)
  • Part VI: Mesenteric Vascular Disease (1180)
    • 25: Epidemiology and Pathophysiology of Mesenteric Vascular Disease (1181)
      • Abstract (1183)
      • Acute arterial occlusive mesenteric ischemia (1184)
      • Mesenteric artery dissection (1190)
      • Nonocclusive mesenteric ischemia (1192)
      • Mesenteric venous thrombosis (1196)
      • Chronic mesenteric ischemia (1199)
    • 26: Clinical Evaluation and Treatment of Mesenteric Vascular Disease (1206)
      • Abstract (1208)
      • Chronic mesenteric ischemia (1210)
      • Acute occlusive mesenteric ischemia (1234)
      • Acute nonocclusive mesenteric ischemia (1243)
      • Mesenteric venous thrombosis (1245)
  • Part VII: Vasculogenic Erectile Dysfunction (1254)
    • 27: Vasculogenic Erectile Dysfunction (1255)
      • Abstract (1257)
      • Definition and classifications (1258)
      • Epidemiology (1259)
      • Public health and clinical implications (1260)
      • Functional anatomy (1261)
      • Pathophysiology of erectile dysfunction (1268)
      • Evaluation of erectile dysfunction (1270)
      • Treatment (1275)
      • Longitudnal psychological outcomes (1280)
      • Guidelines (1281)
  • Part VIII: Cerebrovascular Ischemia (1291)
    • 28: Epidemiology of Cerebrovascular Disease (1292)
      • Abstract (1294)
      • Overview (1295)
      • Stroke risk factors: demographic factors (1300)
      • Stroke risk factors: lifestyle (1302)
      • Medically treatable risk factors (1308)
      • Other risk factors (1315)
      • Awareness of Stroke Warning Signs and Acute Treatment (1319)
      • The future (1320)
    • 29: Clinical Presentation and Diagnosis of Cerebrovascular Disease (1344)
      • Abstract (1346)
      • Overview of clinical stroke (1347)
      • Clinical manifestations of stroke and cerebrovascular disease (1348)
      • Clinical assessment tools (1361)
      • Conclusions (1380)
    • 30: Prevention and Treatment of Stroke (1393)
      • Abstract (1395)
      • Prehospital and emergency department management of ischemic stroke (1400)
      • Acute stroke therapy (1407)
      • Secondary prevention of ischemic stroke (1425)
      • Primary prevention of ischemic stroke (1429)
    • 31: Carotid Artery Revascularization (1452)
      • Abstract (1454)
      • Indications for Carotid Revascularization (1456)
      • Preoperative Management (1458)
      • Carotid Endarterectomy (1460)
      • Carotid Artery Stenting (1464)
      • Postoperative Management (1467)
      • Outcomes for Carotid Endarterectomy and Carotid Artery Stenting (1468)
      • Transcervical Carotid Stenting with Flow Reversal (1471)
      • Management of Postcarotid Endarterectomy Stenosis (1475)
  • Part IX: Aortic Dissection (1481)
    • 32: Pathophysiology, Clinical Evaluation, and Medical Management of Aortic Dissection (1482)
      • Abstract (1484)
      • Epidemiology (1485)
      • Classification (1486)
      • Pathogenesis (1489)
      • Predisposing Genetic Factors (1492)
      • Acquired Disorders (1499)
      • Clinical Presentation (1502)
      • Laboratory Testing (1505)
      • Diagnostic Imaging (1507)
      • Differential Diagnosis (1513)
      • Initial Medical Treatment (Fig. 32.9) (1518)
      • Indications For Intervention (Box 32.5) (1522)
      • Prognosis (1532)
      • Long-Term Surveillance (1535)
    • 33: Surgical Therapy for Aortic Dissection (1552)
      • Abstract (1554)
      • Type a Aortic Dissection (1559)
      • Acute Type B Aortic Dissection (1578)
      • Chronic Type B Aortic Dissection (1582)
      • Future Therapies (1594)
    • 34: Endovascular Therapy for Aortic Dissection (1601)
      • Abstract (1603)
      • Branch Vessel Interventions (1606)
      • Aortic Interventions (1613)
  • Part X: Aortic Aneurysm (1630)
    • 35: Epidemiology and Prognosis of Aortic Aneurysms (1631)
      • Abstract (1633)
      • The Normal Aorta (1634)
      • Definition Of Aortic Aneurysm (1637)
      • Epidemiology And Prognosis Of Aortic Aneurysms (1641)
      • Inherited and Developmental Disorders (1651)
      • Other Conditions Associated with Aortic Aneurysm (1654)
    • 36: Clinical Evaluation of Aortic Aneurysms (1678)
      • Abstract (1680)
      • Clinical history (1681)
      • Physical examination (1684)
      • Screening of aortic aneurysms (1688)
      • Surveillance of aortic aneurysms (1690)
      • Diagnostic testing (1691)
    • 37: Surgical Treatment of Abdominal Aortic Aneurysms (1710)
      • Abstract (1712)
      • Definition (1714)
      • Decision-Making for elective abdominal aortic aneurysm repair (1715)
      • Rupture risk (1717)
      • Expansion rate (1721)
      • Elective operative risk (1723)
      • Life expectancy (1727)
      • Surgical decision-Making (1728)
      • Preoperative assessment (1730)
      • Surgical treatment (1732)
      • Complications of abdominal aortic aneurysm repair (1751)
      • Functional outcome (1757)
      • Long-Term survival (1758)
    • 38: Endovascular Therapy for Abdominal Aortic Aneurysm (1782)
      • Abstract (1784)
      • Indications (1786)
      • Anatomic requirements (1787)
      • Endograft design (1795)
      • Graft placement and postoperative management (1800)
      • Problems with endografting and management (1803)
      • Outcomes (1815)
      • Other considerations (1819)
      • Summary (1825)
  • Part XI: Vasculitis (1843)
    • 39: Overview of Vasculitis (1844)
      • Abstract (1846)
      • Classification of vasculitis (1850)
      • Large-vessel vasculitis (1852)
      • Medium-vessel vasculitis (1858)
      • Small-vessel vasculitis (1861)
      • VARIABLE-VESSEL VASCULITIS (1868)
      • Evaluation and diagnosis of possible vasculitis (1873)
      • Treatment of vasculitis (1883)
    • 40: Large Vessel Vasculitis (1895)
      • Abstract (1897)
      • Acknowledgment (1898)
      • Takayasu arteritis (1899)
      • Giant cell arteritis (1916)
      • Isolated idiopathic aortitis (1936)
    • 41: Medium and Small Vessel Vasculitis (1953)
      • Abstract (1955)
      • Medium vessel vasculitis (1956)
      • Small vessel vasculitis (1966)
      • Pauci-immune small vessel vasculitis (1974)
      • Immune complex mediated small vessel vasculitis (1985)
    • 42: Thromboangiitis Obliterans (Buerger Disease) (2018)
      • Abstract (2020)
      • Epidemiology (2022)
      • Etiology and pathogenesis (2023)
      • Pathology (2026)
      • Clinical presentation (2031)
      • Differential diagnosis (2035)
      • Diagnosis (2038)
      • Prognosis (2045)
      • Management (2046)
      • Future perspectives (2055)
    • 43: Kawasaki Disease (2060)
      • Abstract (2062)
      • Epidemiology (2064)
      • Etiology and pathogenesis (2065)
      • Pathology (2067)
      • Clinical presentation (2070)
      • Cardiac manifestations (2073)
      • Cardiac testing (2075)
      • Clinical course (2078)
      • Treatment (2082)
      • Coronary revascularization for late stenosis (2086)
      • Preventive cardiology (2088)
      • Summary (2089)
  • Part XII: Acute Limb Ischemia (2107)
    • 44: Acute Arterial Occlusion (2108)
      • Abstract (2110)
      • Epidemiology of acute limb ischemia (2112)
      • Etiology of acute limb ischemia (2114)
      • Pathophysiology of acute limb ischemia (2121)
      • Diagnosis of acute limb ischemia (2124)
      • Treatment of acute limb ischemia (2127)
    • 45: Atheroembolism (2165)
      • Abstract (2167)
      • Pathobiology (2174)
      • Etiology (2175)
      • Atheroembolic syndromes (2186)
      • General treatment measures for atheroembolic disease prevention (2210)
      • Conclusions (2212)
  • Part XIII: Vasospasm and Other Related Vascular Diseases (2227)
    • 46: Raynaud Phenomenon (2228)
      • Abstract (2230)
      • Overview of primary raynaud phenomenon (2236)
      • Pathophysiology (2239)
      • Secondary Causes of Raynaud Phenomenon (2247)
      • Diagnostic tests (2257)
      • Treatment (2263)
    • 47: Acrocyanosis (2283)
      • Abstract (2285)
      • Epidemiology (2287)
      • Etiology (2288)
      • Pathophysiology (2290)
      • Clinical presentation (2292)
      • Diagnosis (2294)
      • Histopathology (2295)
      • Differential diagnosis (2296)
      • Treatment (2298)
      • Prognosis (2300)
    • 48: Erythromelalgia (2304)
      • Abstract (2306)
      • Definition and historical perspective (2307)
      • Nomenclature (2308)
      • Criteria for diagnosis (2309)
      • Clinical controversies (2311)
      • Clinical presentation (2312)
      • Diagnosis (2316)
      • Classification (2317)
      • Incidence (2320)
      • Pathophysiology (2321)
      • Differential diagnosis (2326)
      • Investigations (2327)
      • Natural History and Prognosis (2329)
      • Management (2331)
    • 49: Pernio (Chilblains) (2343)
      • Abstract (2345)
      • Epidemiology (2349)
      • Pathophysiology (2350)
      • Histopathology (2353)
      • Clinical features (2355)
      • Diagnosis (2363)
      • Treatment (2365)
  • Part XIV: Venous Thromboembolic Disease (2372)
    • 50: Epidemiology of Venous Thromboembolic Disease (2373)
      • Abstract (2375)
      • Incidence and clinical relevance of venous thromboembolism (2376)
      • Secular trends in incidence of venous thromboembolism (2377)
      • Risk factors for venous thromboembolism (2380)
      • Classification of venous thromboembolism (2383)
      • Incidental venous thromboembolism (2385)
      • Conclusion (2386)
    • 51: Clinical Evaluation of Venous Thromboembolism (2391)
      • Abstract (2393)
      • Clinical Presentation (2394)
      • Diagnosis (2398)
      • Diagnosis in Pregnancy (2416)
      • Risk Stratification (2418)
      • Adjunctive Clinical Evaluation for Etiology of Venous Thromboembolism (2424)
    • 52: Management of Venous Thromboembolism (2436)
      • Abstract (2438)
      • Pathophysiology and Risk Factors for Venous Thromboembolism (2441)
      • Anticoagulation (2446)
      • Recurrent Venous Thromboembolism and Optimal Duration of Anticoagulation (2459)
      • Advanced Management of Venous Thromboembolism: When Anticoagulation Alone May Not or Will Not Suffice (2462)
      • Strategies for Managing Acute Venous Thromboembolism (2471)
      • The Multitude of Challenges in Managing Venous Thrombosis (2475)
      • A Look Into the Future (2477)
  • Part XV: Chronic Venous Disorders (2494)
    • 53: Varicose Veins (2495)
      • Abstract (2497)
      • Epidemiology (2498)
      • Anatomy (2499)
      • Pathogenesis (2504)
      • Clinical manifestations (2506)
      • Physical examination (2508)
      • Imaging and physiological testing (2513)
      • Management (2515)
      • Management of incompetent perforator veins (2535)
      • Management of telangiectasia/reticular veins (2538)
      • Follow-up and prognosis (2540)
    • 54: Chronic Venous Insufficiency (2552)
      • Abstract (2554)
      • Anatomy (2557)
      • Etiology (2560)
      • Pathophysiology (2561)
      • Diagnosis (2564)
      • Treatment (2577)
      • Conclusions (2595)
  • Part XVI: Pulmonary Hypertension (2614)
    • 55: Pulmonary Arterial Hypertension (2615)
      • Abstract (2617)
      • Definition and classification of pulmonary arterial hypertension (2618)
      • Epidemiology (2620)
      • Cellular pathogenesis of pulmonary arterial hypertension (2621)
      • Molecular pathogenesis of pulmonary arterial hypertension (2627)
      • Clinical pathophysiology (2656)
      • Treatment (2668)
      • Conclusions (2682)
    • 56: Pulmonary Hypertension in Patients With Nonpulmonary Arterial Hypertension (2709)
      • Abstract (2711)
      • Overview of pulmonary hypertension (2712)
      • Pulmonary venous hypertension (2719)
      • Pulmonary hypertension under conditions of hypoxemia (2726)
      • Pulmonary hypertension secondary to pulmonary thromboembolic disease (2730)
      • Pulmonary hypertension and hemoglobinopathies (2736)
      • Other secondary causes of pulmonary hypertension (2741)
  • Part XVII: Lymphatic Disorders (2756)
    • 57: Diseases of the Lymphatic Circulation (2757)
      • Abstract (2759)
      • Anatomy of the lymphatic circulation (2761)
      • Physiology of the lymphatic circulation (2765)
      • Lymphatic insufficiency (Lymphedema) (2768)
      • Diseases of the lymphatic vasculature (2793)
  • Part XVIII: Miscellaneous (2810)
    • 58: Fibromuscular Dysplasia (2811)
      • Abstract (2813)
      • Historical perspective (2815)
      • Classification (2816)
      • Epidemiology (2820)
      • Genetics and etiology (2822)
      • Clinical presentation and vascular manifestations (2825)
      • Diagnostic evaluation of fibromuscular dysplasia (2845)
      • Imaging studies for diagnosis of fibromuscular dysplasia (2849)
      • Management of fibromuscular dysplasia (2853)
      • Endovascular therapy for fibromuscular dysplasia (2858)
      • Surgery for fibromuscular dysplasia (2862)
      • Follow-up and prognosis (2863)
    • 59: Vascular Infections (2882)
      • Abstract (2884)
      • Primary arterial infections (2886)
      • Secondary arterial infections (2897)
      • Diagnostic Tests to Aid the Diagnosis of Arterial Infections (2906)
      • Management of Primary and Secondary Arterial Infections (2915)
      • Suppurative thrombophlebitis (2933)
      • Septic cavernous sinus thrombosis (2937)
      • Conclusions (2938)
    • 60: Dermatological Manifestations of Vascular Disease (2952)
      • Abstract (2954)
      • Peripheral artery disease (2956)
      • Vasomotor diseases (2961)
      • Acrocyanosis (2969)
      • Erythromelalgia (2973)
      • Pernio/chilblains disease (2977)
      • Livedo reticularis (2982)
      • Hybrid vasomotor disease (2986)
      • Chronic venous insufficiency (2989)
      • Lymphedema (3003)
    • 61: Lower Extremity Ulceration (3019)
      • Abstract (3021)
      • Biomechanics of walking and ulcer formation (3025)
      • Pathophysiology of ulcer formation (3028)
      • Assessment of the patient with a lower extremity ulcer (3037)
      • Management of ulcers (3045)
      • Summary (3051)
    • 62: Vascular Trauma (3061)
      • Abstract (3063)
      • Initial evaluation (3066)
      • Types of vessel injury (3067)
      • Mechanism: Penetrating vs. Blunt trauma (3069)
      • Signs of vascular injury (3070)
      • Neck vascular trauma (3072)
      • Specific NECK VASCULAR injuries (3074)
      • Thoracic vascular trauma (3076)
      • Specific THORACIC VASCULAR injuries (3078)
      • Abdominal vascular trauma (3084)
      • Specific ABDOMINAL VASCULAR injuries (3087)
      • Extremity vascular trauma (3095)
      • Specific EXTREMITY VASCULAR injuries (3096)
      • Ischemia-Reperfusion Injury (3099)
      • Compartment Syndrome (3100)
      • Iatrogenic Vascular Injury (3102)
      • Pediatric Vascular Trauma (3104)
    • 63: Vascular Compression Syndromes (3112)
      • Abstract (3114)
      • Thoracic outlet syndrome (3115)
      • Axillary artery compression syndrome (3124)
      • Median arcuate ligament syndrome (3125)
      • Nutcracker syndrome (3129)
      • May-thurner syndrome (3133)
      • Popliteal entrapment syndrome (3136)
      • Cystic adventitial disease (3140)
    • 64: Peripheral Vascular Anomalies, Malformations, and Vascular Tumors (3158)
      • Abstract (3160)
      • Proliferative vascular anomalies and tumors (3163)
      • Vascular malformations (3178)
      • Syndromic vascular anomalies (3190)
      • Treatment of vascular malformations (also see Table 64.3) (3195)
      • Prenatal diagnosis of vascular anomalies (3198)
      • Clinical issues (see also Table 64.4) (3199)
  • Index (3222)
Loading...